OptimizeRx Expands Exclusive Partnership with Allscripts for Prescription Cost Savings and Real-time Messaging at Point-of-Ca...
January 09 2018 - 10:20AM
OptimizeRx Corp. (OTCQB:OPRX), the nation’s leading provider of
digital health messaging, has expanded its partnership with
Allscripts Healthcare (NASDAQ:MDRX) which now includes a variety of
real-time messaging to Allscripts ambulatory platforms. The
agreement includes financial, informational, and clinical messaging
delivered at the point-of-care through Allscripts ePrescribe™,
Allscripts Professional EHR™ and Allscripts TouchWorks® EHR
solutions.
“Our goal at OptimizeRx is to help make medications more
affordable, encourage greater adherence, and provide important
clinical information,” commented Miriam Paramore, president of
OptimizeRx. “Supported by our pharma partners, OptimizeRx and
Allscripts continue to empower healthcare providers to make better
decisions and deliver better, more affordable care for healthier
patients, populations and communities.”
Allscripts’ industry leading electronic health record (EHR) and
ePrescribing (eRx) network totals more than 180,000 physicians
across 45,000 ambulatory facilities, 2,500 hospitals and 17,000
post-acute organizations. In 2017, Allscripts achieved an
industry-leading milestone of one billion data exchange
transactions through its platform – the most in a single year.
OptimizeRx’s growing EHR and eRx network now reaches more than
500,000 healthcare providers (HCPs) in the U.S., making it the
healthcare industry’s largest point-of-prescribe network. It
delivers real-time access to financial assistance, education, and
critical clinical information from pharma companies to HCPs.
“Our long-running relationship with Allscripts, a recognized
global leader in healthcare information technology, reflects the
unmatched value proposition we offer to our EHR and pharma
manufacturer partners,” said William Febbo, CEO of OptimizeRx.
“Allscripts’ continued innovation around real-time messaging on its
network helps sets the stage for stronger revenue growth and pharma
partner relationships in the New Year.”
About OptimizeRxOptimizeRx® (OTCQB:OPRX) is the
nation’s leading provider of digital health messaging via
electronic health records (EHRs), providing a direct channel for
pharma companies to communicate with healthcare providers. The
company’s cloud-based solution supports patient adherence to
medications by providing real-time access to financial assistance,
prior authorization, education, and critical clinical information.
The company’s network is comprised of leading EHR platforms like
Allscripts, Amazing Charts and Quest, and provides more than half a
million healthcare providers access to these benefits within their
workflow at the point of care. For more information, follow the
company on Twitter, LinkedIn or visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
StatementsThis press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended and such section 21E of the Securities Act
of 1934, amended. These forward-looking statements should not be
used to make an investment decision. The words 'estimate,'
'possible' and 'seeking' and similar expressions identify
forward-looking statements, which speak only as to the date the
statement was made. The company undertakes no obligation to
publicly update or revise any forward-looking statements, whether
because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition and other material
risks.
OptimizeRx Contact:Doug Baker, CFOTel (248)
651-6568 x807dbaker@optimizerx.com
OptimizeRx Investor Relations:Ron Both, CMATel
(949) 432-7557oprx@cma.team
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Apr 2023 to Apr 2024